Oral transmucosal fentanyl citrate in the management of dyspnea crisis in cancer patients

被引：20
作者：
Benitez-Rosario, MA [1 ]
Martin, AS
Feria, M
机构：
[1] Hosp La Candelaria, Palliat Care Unit, Tenerife, Spain
[2] Hosp La Candelaria, Res Unit, Tenerife, Spain
[3] Univ La Laguna, Dept Pharmacol, Tenerife, Spain
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2005年 / 30卷 / 05期
关键词：
D O I：
10.1016/j.jpainsymman.2005.10.002
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：395 / 397
页数：3
相关论文
共 6 条
  • [1] Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)
    Coluzzi, PH
    Schwartzberg, L
    Conroy, JD
    Charapata, S
    Gay, M
    Busch, MA
    Chavez, J
    Ashley, J
    Lebo, D
    McCracken, M
    Portenoy, RK
    [J]. PAIN, 2001, 91 (1-2) : 123 - 130
  • [2] Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea
    Coyne, PJ
    Viswanathan, R
    Smith, TJ
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (02) : 157 - 160
  • [3] Dyspnea in cancer patients: Prevalence and associated factors
    Dudgeon, DJ
    Kristjanson, L
    Sloan, JA
    Lertzman, M
    Clement, K
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 21 (02) : 95 - 102
  • [4] A systematic review of the use of opioids in the management of dyspnoea
    Jennings, AL
    Davies, AN
    Higgins, JPT
    Gibbs, JSR
    Broadley, KE
    [J]. THORAX, 2002, 57 (11) : 939 - 944
  • [5] PALLIATION OF SYMPTOMS IN NONSMALL CELL LUNG-CANCER - A STUDY BY THE YORKSHIRE-REGIONAL-CANCER-ORGANIZATION THORACIC GROUP
    MUERS, MF
    ROUND, CE
    [J]. THORAX, 1993, 48 (04) : 339 - 343
  • [6] Thomas Jay R, 2003, J Support Oncol, V1, P23
1